GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: compound A [WO2023149450A1] | CTX-177 | CTX177
Compound class:
Synthetic organic
Comment: The chemical structure for ocipumaltib was included in WHO INN proposed list 133 (10th July 2025). It is one of the compounds claimed as MALT1 paracaspase inhibitors in patent WO2023149450A1 [1], making this likely to be the INN for Chordia Therapeutics' clinical lead CTX-177. MALT1 is a therapeutic target for the treatment of lymphomas in which the protein is aberrantly activated.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| 1-[6-chloro-4-[(1S)-1-methoxyethyl]-1,5-naphthyridin-3-yl]-3-[6-(triazol-2-yl)-5-(trifluoromethyl)pyridin-3-yl]urea |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 13582 | ocipumaltib |
Synonyms ![]() |
| compound A [WO2023149450A1] | CTX-177 | CTX177 |
Database Links ![]() |
|
| GtoPdb PubChem SID | 518520677 |
| PubChem CID | 151085091 |
| Search Google for chemical match using the InChIKey | MKYDKGUTYKFCHS-JTQLQIEISA-N |
| Search Google for chemicals with the same backbone | MKYDKGUTYKFCHS |
| Search PubMed clinical trials | ocipumaltib |
| Search PubMed titles | ocipumaltib |
| Search PubMed titles/abstracts | ocipumaltib |
| UniChem Compound Search for chemical match using the InChIKey | MKYDKGUTYKFCHS-JTQLQIEISA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | MKYDKGUTYKFCHS-JTQLQIEISA-N |